SandboxAlonso: Difference between revisions
Jump to navigation
Jump to search
Line 70: | Line 70: | ||
{{familytree | | | | | C01 | | | | | | | | C02 | | | C01=Perform specific [[EGFR]] and ALK mutation testing: What is the specific mutation?|C02=Is the patient smoker or former smoker?}} | {{familytree | | | | | C01 | | | | | | | | C02 | | | C01=Perform specific [[EGFR]] and ALK mutation testing: What is the specific mutation?|C02=Is the patient smoker or former smoker?}} | ||
{{familytree | |,|-|-|-|+|-|-|-|.| | | | | |!| | |}} | {{familytree | |,|-|-|-|+|-|-|-|.| | | | | |!| | |}} | ||
{{familytree | D01 | | D02 | | D03 | | | | D04 | | | D01=Sensitizing [[EGFR]] mutation|D02=ALK mutation|D03=Negative [[EGFR]] and ALK|D04=Click here for the squamous cell carcinoma specific treatment}} | {{familytree | D01 | | D02 | | D03 | | | | D04 | | | D01=Sensitizing [[EGFR]] mutation|D02=ALK mutation|D03=Negative [[EGFR]] and ALK|D04=[[Non small cell carcinoma of the lung medical therapy#Metastatic squamous cell carcinoma|Click here for the squamous cell carcinoma specific treatment]]}} | ||
{{familytree | |!| | | |!| | | |!| | | | |}} | {{familytree | |!| | | |!| | | |!| | | | |}} | ||
{{familytree | E01 | | E02 | | E03 | | | E01=[[Non small cell carcinoma of the lung medical therapy#Positive sensitizing EGFR mutation|Click here for the sensitizing EGFR mutation specific treatment]]|E02=[[Non small cell carcinoma of the lung medical therapy#Positive ALK | {{familytree | E01 | | E02 | | E03 | | | E01=[[Non small cell carcinoma of the lung medical therapy#Positive sensitizing EGFR mutation|Click here for the sensitizing EGFR mutation specific treatment]]|E02=[[Non small cell carcinoma of the lung medical therapy#Positive ALK mutation|Click here for the specific therapy for the ALK mutation specific treatment]]|E03=[[Non small cell carcinoma of the lung medical therapy#Negative EGRF and ALK or unknown mutation|Click here for the treatment of negative sensitizing EGFR and ALK mutation metastatic disease]]}} | ||
{{familytree/end}} | {{familytree/end}} |
Revision as of 16:11, 20 June 2014
Stage IV
Is pleural or pericardial effusion present (suggestive of M1a) or are findings suggestive of systemic metastasis (M1b) present? | |||||||||||||||||||||||||||||||||||||||||||||
M1a | M1b | ||||||||||||||||||||||||||||||||||||||||||||
Perform the following tests:
| Perform the following tests:
| ||||||||||||||||||||||||||||||||||||||||||||
Is the liquid extracted positive for malignant cells? | Are findings suggestive of adrenal metastasis or brain metastasis? | ||||||||||||||||||||||||||||||||||||||||||||
Yes | No | Adrenal | Brain | ||||||||||||||||||||||||||||||||||||||||||
Local therapy
PLUS | Perform a needle aspiration biopsy for metastasis confirmation | Surgical resection + adjuvant radiation therapy Radiation therapy alone:
PLUS | |||||||||||||||||||||||||||||||||||||||||||
What is the TN stage of the lung tumor? | |||||||||||||||||||||||||||||||||||||||||||||
|
| ||||||||||||||||||||||||||||||||||||||||||||
| Administer therapy for metastatic disease in case of not curable lung lesions (click here for the treatment of local and systemic metastasis and neoplastic recurrence) | ||||||||||||||||||||||||||||||||||||||||||||
Metastatic disease
What the specific subtype according to the specific histological characteristics of the tumor? | |||||||||||||||||||||||||||||||||||||||
| Squamous cell carcinoma | ||||||||||||||||||||||||||||||||||||||
Perform specific EGFR and ALK mutation testing: What is the specific mutation? | Is the patient smoker or former smoker? | ||||||||||||||||||||||||||||||||||||||
Sensitizing EGFR mutation | ALK mutation | Negative EGFR and ALK | Click here for the squamous cell carcinoma specific treatment | ||||||||||||||||||||||||||||||||||||
Click here for the sensitizing EGFR mutation specific treatment | Click here for the specific therapy for the ALK mutation specific treatment | Click here for the treatment of negative sensitizing EGFR and ALK mutation metastatic disease | |||||||||||||||||||||||||||||||||||||